Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes EP News Bureau Jul 10, 2021 It is a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR…
